Sionna Therapeutics, Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$7.25-$45
Market Cap
$1.9B
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$1.80

News

See more

Yahoo Finance • 2 days ago

Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls

Yahoo Finance • last month

Sionna Therapeutics to Participate in Upcoming December Investor Conferences

Yahoo Finance • 2 months ago

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference

Yahoo Finance • 2 months ago

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis

About

CEO
Mr. Michael Cloonan M.B.A.
Address
21 Hickory Drive, Waltham, MA, United States, 02451
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
41